Vendor, Boston, MA, part of University of Massachusetts
University of Massachusetts Biologic Labs
UEI GT9FULQPXLP3, CAGE 6T336
2 awards and -$138,200 obligated between April 10, 2024 and July 25, 2025, 0% under full and open competition, against 1.0 offers on average where reported.
Sells to
Awarding agencies by dollars.
| National Institutes of Health | -$13,200 |
| Centers for Disease Control and Prevention | -$125,000 |
Industries
NAICS on the awards, by dollars.
| In-Vitro Diagnostic Substance ManufacturingNAICS 325413 | -$13,200 |
| Pharmaceutical Preparation ManufacturingNAICS 325412 | -$125,000 |
How it wins
Awards by competition, set-aside and type.
| Not Competed Under SAP | 1 |
| Not Competed | 1 |
| Purchase Order | 2 |
Awards
Every award in the window, by dollars obligated.
| Contract | Awarding office | Described as | Obligated |
|---|---|---|---|
| 75N93020P01182Purchase Order, July 25, 2025, Not Competed Under SAP, 1 offers | National Institutes of Health NiaidNational Institutes of Health | Depleting Rhesus Recombinants Qty 44NAICS 325413, PSC 6505 | -$13,200 |
| 75D30123P16354Purchase Order, April 10, 2024, Not Competed, 1 offers | CDC Office of Acquisition ServicesCenters for Disease Control and Prevention | 25 Doses of Edat 160,000IUNAICS 325412, PSC Q999 | -$125,000 |
- Places of performance
- MassachusettsGeorgia
- Product and service codes
- 6505 Drugs and BiologicalsQ999 Other Medical Services
- Transactions
- 2 across 2 awards